Advances in antiepileptic drug development

Author(s):  
Philip N Patsalos
Drugs ◽  
2008 ◽  
Vol 68 (1) ◽  
pp. 17-25 ◽  
Author(s):  
Catherine Chiron ◽  
Olivier Dulac ◽  
Gerard Pons

2015 ◽  
pp. 61-74 ◽  
Author(s):  
Dieter Schmidt

2003 ◽  
Vol 466 (1-2) ◽  
pp. 99-111 ◽  
Author(s):  
Wolfgang Löscher ◽  
Heidrun Potschka ◽  
Piotr Wlaź ◽  
Wojciech Danysz ◽  
Christopher G Parsons

Author(s):  
Donald F. Weaver

ABSTRACT:There is still no medical cure for epilepsy. Clinical epileptology is in need of a “paradigm shift” when it comes to the continuing development of therapeutics. An important first step in this conceptual evolution is differentiating between the notions of ictogenesis and epileptogenesis. All traditional therapeutics are anti-ictogenic, not antiepileptogenic. The future of antiepileptic drug development lies in the discovery of antiepileptogenics. Just as aspirin is not the drug of choice for meningitis, an anticonvulsant is not the drug of choice for epilepsy. Drug design for epilepsy needs to discover a penicillin, not more aspirins.


Neurology ◽  
2001 ◽  
Vol 56 (4) ◽  
pp. 514-519 ◽  
Author(s):  
J. A. Racoosin ◽  
J. Feeney ◽  
G. Burkhart ◽  
G. Boehm

Sign in / Sign up

Export Citation Format

Share Document